Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 6/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CASP6 | P55212 | 1/20 | 0.46 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.45 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.43 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.43 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30946522 | 1.00 | TDP1 (0.52) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL7513494 | 0.88 | ALDH1A1 (0.48) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL3302919 | 0.85 | TSHR (0.56) | TDP1ATMALDH1A1HIF1ATSHR | |
| SCHEMBL30924883 | 0.84 | TDP1 (0.50) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL825499 | 0.84 | TDP1 (0.50) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL73931 | 0.84 | TDP1 (0.50) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL10526798 | 0.81 | TDP1 (0.48) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL15347823 | 0.81 | TDP1 (0.47) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL397110 | 0.81 | TDP1 (0.52) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL8817806 | 0.81 | TDP1 (0.47) | TDP1ATMALDH1A1HIF1AVCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118179542-A | Carbon-based catalyst, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-20220193475-A1 | ZERO-VALENT METAL AND BLACK CARBON FRAMEWORK AND METHOD OF USING SAME | MUNIREM ENVIRONMENTAL, LLC | 2022-06-23 | — | — | US | claimed |
| CN-118179542-A | Carbon-based catalyst, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| US-20220193475-A1 | ZERO-VALENT METAL AND BLACK CARBON FRAMEWORK AND METHOD OF USING SAME | MUNIREM ENVIRONMENTAL, LLC | 2022-06-23 | — | — | US | disclosed |
| CN-113943432-A | Mask with long-acting sterilization function | 孙国明 | 2022-01-18 | — | — | CN | disclosed |
| EP-3423096-A1 | POLYMALIC ACID BASED NANOIMMUNOCONJUGATES AND USES THEREOF | Cedars-Sinai Medical Center (US) | 2019-01-09 | — | — | EP | disclosed |
| CN-108341840-A | The preparation method of Ceftaroline Fosamil | 深圳华润九新药业有限公司 | 2018-07-31 | — | — | CN | disclosed |
| US-20140113371-A1 | Cryopreservation of Haptenized Tumor Cells | BERD DAVID (US) | 2014-04-24 | — | — | US | disclosed |
| US-8435784-B2 | Cryopreservation of haptenized tumor cells | THOMAS JEFFERSON UNIVERSITY | 2013-05-07 | — | — | US | disclosed |
| CN-102283899-B | Traditional Chinese medicine external preparation and application thereof | HUNAN PUTIANCHUN BIOLOG TECHNOLOGY CO LTD | 2012-06-27 | — | — | CN | disclosed |
| CN-102283899-A | Traditional Chinese medicine external preparation and application thereof | — | 2011-12-21 | — | — | CN | disclosed |
| WO-2001056612-A9 | ANIMAL MODEL FOR TESTING OF IMMUNOTHERAPIES | UNIV ILLINOIS (US) | 2002-10-24 | — | — | WO | disclosed |
| US-20020009469-A1 | Low dose haptenized tumor cell and tumor cell extract immunotherapy | THOMAS JEFFERSON UNIVERSITY | 2002-01-24 | — | — | US | disclosed |
| US-20010046502-A1 | Animal model for testing immunotherapies of spontaneous metastatic disease | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2001-11-29 | — | — | US | disclosed |
| WO-2001056612-A2 | ANIMAL MODEL FOR TESTING OF IMMUNOTHERAPIES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2001-08-09 | — | — | WO | disclosed |
| WO-2001056601-A2 | LOW DOSE HAPTENIZED TUMOR CELL AND TUMOR CELL EXTRACT IMMUNOTHERAPY | THOMAS JEFFERSON UNIVERSITY (US) | 2001-08-09 | — | — | WO | disclosed |
| WO-2000038710-A2 | DUAL HAPTEN MODIFIED TUMOR CELLS AND TUMOR POLYPEPTIDES AND METHODS OF TREATING CANCER | THOMAS JEFFERSON UNIVERSITY (US) | 2000-07-06 | — | — | WO | disclosed |
| CN-1198947-A | Chinese medicine as immunity regulator and its preparation process | WEI QILIAN (CN) | 1998-11-18 | — | — | CN | disclosed |
| US-5106762-A | Hydrophilic oligopeptides containing luminescent or fluorescent labels and metal or ammonium salt groups; immunoassay; water solubility; sensitivity | GEORGETOWN UNIVERSITY (US) | 1992-04-21 | — | — | US | disclosed |
| WO-1991016344-A1 | LIGAND-LABEL CONJUGATES WHICH CONTAIN POLYOXOANIONS OF SULFUR OR PHOSPHORUS | GEORGETOWN UNIVERSITY (US) | 1991-10-31 | — | — | WO | disclosed |